This topic contains a solution. Click here to go to the answer

Author Question: Elevated levels of glucocorticoids result in which of the following assessment findings? (select all ... (Read 50 times)

c0205847

  • Hero Member
  • *****
  • Posts: 531
Elevated levels of glucocorticoids result in which of the following assessment findings? (select all that apply)
 
  a. Polycythemia
  b. Increased appetite
  c. Weight loss
  d. Decreased calcium
  e. Increased height

Question 2

Where is the main site of aldosterone synthesis?
 
  a. Liver
  b. Kidneys
  c. Adrenal cortex
  d. Hypothalamus



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dajones82

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

ANS: A, B, D
Increased glucocorticoid secretion leads to polycythemia, increased appetite, fat deposition in the face and cervical areas, decreased serum calcium levels, and interference with the action of growth hormone so that somatic growth is inhibited. Weight gain and loss of height are expected.

Answer to Question 2

ANS: C
The adrenal cortex, not the liver, kidneys, or the hypothalamus, synthesizes aldosterone.




c0205847

  • Member
  • Posts: 531
Reply 2 on: Jun 25, 2018
Excellent


kilada

  • Member
  • Posts: 311
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

For a complete list of videos, visit our video library